S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture

Puma Biotechnology (PBYI) Earnings Date, Estimates & Call Transcripts

$6.55
+0.64 (+10.83%)
(As of 02/23/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

PBYI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PBYI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Puma Biotechnology Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q2 20241$0.06$0.06$0.06 
Q3 20241$0.08$0.08$0.08 
Q4 20241$0.22$0.22$0.22 
20243$0.36$0.36$0.36 
Q1 20251$0.08$0.08$0.08 
Q3 20251$0.14$0.14$0.14 
Q4 20251$0.22$0.22$0.22 

PBYI Earnings Date and Information

Puma Biotechnology has confirmed that its next quarterly earnings report will be published on Thursday, February 29th, 2024. Puma Biotechnology will be holding an earnings conference call on Thursday, February 29th at 4:30 PM Eastern. Interested parties can register for or listen to the call..

Puma Biotechnology Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
2/29/2024
Confirmed)
-------  
11/2/2023Q3 2023$0.08$0.12+$0.04$0.12$57.30 million$56.10 million
8/3/2023Q2 2023$0.02$0.05+$0.03$0.05$51.37 million$54.60 million
5/4/2023Q1 2023($0.10)$0.03+$0.13$0.03$49.71 million$52.80 million
3/2/2023Q4 2022$0.06($0.12)($0.18)($0.12)$57.10 million$65.70 million
11/3/2022Q3 2022($0.11)($0.01)+$0.10($0.01)$51.40 million$57.10 million
8/4/2022Q2 2022$0.02$0.21+$0.19$0.21$53.20 million$59.50 million
5/5/2022Q1 2022($0.13)($0.08)+$0.05($0.08)$45.07 million$45.70 million    
3/3/2022Q4 2021($0.11)$0.10+$0.21$0.10$47.17 million$55.40 million    
11/4/2021Q3 2021($0.31)($1.09)($0.78)($1.09)$53.44 million$46.20 million    
8/5/2021Q2 2021($0.31)($0.13)+$0.18($0.13)$51.01 million$53.40 million    
5/6/2021Q1 2021$0.29$0.40+$0.11$0.40$74.55 million$98.20 million  
2/24/2021Q4 2020($0.31)($0.38)($0.07)($0.38)$52.31 million$52.60 million  












Puma Biotechnology Earnings - Frequently Asked Questions

When is Puma Biotechnology's earnings date?

Puma Biotechnology has confirmed that its next quarterly earnings data will be published on Thursday, February 29th, 2024. Learn more on PBYI's earnings history.

How much revenue does Puma Biotechnology generate each year?

Puma Biotechnology (NASDAQ:PBYI) has a recorded annual revenue of $228 million.

What is Puma Biotechnology's price-to-earnings ratio?

Puma Biotechnology (NASDAQ:PBYI) has a trailing price-to-earnings ratio of 81.88 and a forward price-to-earnings ratio of 12.60. The price/earnings-to-growth ratio is 1.97.

What is Puma Biotechnology's EPS forecast for next year?

Puma Biotechnology's earnings are expected to decrease from $0.52 per share to $0.49 per share in the next year, which is a -5.77% change.


More Earnings Resources from MarketBeat

This page (NASDAQ:PBYI) was last updated on 2/24/2024 by MarketBeat.com Staff